Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits

被引:121
作者
Pisella, PJ
Fillacier, K
Elena, PP
Debbasch, C
Baudouin, C
机构
[1] Univ Paris 05, Toxicol Lab, Paris, France
[2] Hop Ambroise Pare, APHP, Dept Ophthalmol, Boulogne, France
[3] XV XX Hosp, Dept Cellular Pharmacotoxicol, Paris, France
[4] Univ Nice, Dept Ophthalmol, F-06108 Nice 2, France
[5] Iris Pharma, La Gaude, France
关键词
benzalkonium; preservative; conjunctiva; cornea; glaucoma; toxicity;
D O I
10.1159/000055579
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Thirty-six albino rabbits, randomly divided into six groups, were used to study their ocular tolerance to (a) 0.25 and 0.50% Timoptol(R) preserved with 0.01% benzalkonium chloride, (b) 0.25 and 0.50% Timoptol-LP(R), a gel-forming solution preserved with 0.012% benzododecinium bromide, and (c) 0.25 and 0.50% Timabak(R) unpreserved in the ABAK(R) eyedrops dispenser, All eyedrops were applied in the right eye for 60 days, A clinical follow-up with slitlamp examination and break-up time evaluation was performed for 2 months. At the end of the experimentation, the animals were sacrificed and their eyes enucleated for histological analyses of the conjunctiva and cornea, There was no significant difference in the clinical examination between each group, except for the break-up time evaluation between Timoptol and Timabak at each concentration which was better with the unpreserved timolol, Histological results showed a significant difference in the corneal stroma edema between preserved and unpreserved timolol, This study confirms that using unpreserved timolol may be beneficial for the long-term treatment of glaucomatous patients as it increases tear film stability and decreases epithelial permeability and stromal aggression of the cornea, Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:3 / 8
页数:6
相关论文
共 19 条
[1]  
BAINES MG, 1991, INVEST OPHTH VIS SCI, V32, P2259
[2]   Ocular surface inflammatory changes induced by topical antiglaucoma drugs -: Human and animal studies [J].
Baudouin, C ;
Pisella, PJ ;
Fillacier, K ;
Goldschild, M ;
Becquet, F ;
De Saint Jean, M ;
Béchetoille, A .
OPHTHALMOLOGY, 1999, 106 (03) :556-563
[3]  
BAUDOUIN C, 1994, OPHTHALMOLOGY, V101, P454
[4]   Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface [J].
Becquet, F ;
Goldschild, M ;
Moldovan, MS ;
Ettaiche, M ;
Gastaud, P ;
Baudouin, C .
CURRENT EYE RESEARCH, 1998, 17 (04) :419-425
[5]   ADVERSE-EFFECTS OF TOPICAL ANTIGLAUCOMATOUS MEDICATIONS ON THE CONJUNCTIVA [J].
BRAODWAY, D ;
GRIERSON, I ;
HITCHINGS, R .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (09) :590-596
[6]   ADVERSE-EFFECTS OF TOPICAL ANTIGLAUCOMA MEDICATION .1. THE CONJUNCTIVAL CELL PROFILE [J].
BROADWAY, DC ;
GRIERSON, I ;
OBRIEN, C ;
HITCHINGS, RA .
ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (11) :1437-1445
[7]   CORNEAL CYTO-TOXICITY OF TOPICALLY APPLIED DRUGS, VEHICLES AND PRESERVATIVES [J].
BURSTEIN, NL .
SURVEY OF OPHTHALMOLOGY, 1980, 25 (01) :15-30
[8]  
BURSTEIN NL, 1985, T OPHTHAL SOC UK, V104, P402
[9]  
BURSTEIN NL, 1980, INVEST OPHTH VIS SCI, V19, P308
[10]  
COLLIN HB, 1982, AM J OPTOM PHYS OPT, V59, P215